Impact of Non-HIV and HIV Risk Factors on Survival in HIV-Infected Patients on HAART: A Population-Based Nationwide Cohort Study
We determined the impact of three factors on mortality in HIV-infected patients who had been on highly active antiretroviral therapy (HAART) for at least one year: (1) insufficient response to (HAART) and presence of AIDS-defining diseases, (2) comorbidity, and (3) drug and alcohol abuse and compare...
Gespeichert in:
| Veröffentlicht in: | PloS one Jg. 6; H. 7; S. e22698 |
|---|---|
| Hauptverfasser: | , , , , , , , |
| Format: | Journal Article |
| Sprache: | Englisch |
| Veröffentlicht: |
United States
Public Library of Science
25.07.2011
Public Library of Science (PLoS) |
| Schlagworte: | |
| ISSN: | 1932-6203, 1932-6203 |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| Abstract | We determined the impact of three factors on mortality in HIV-infected patients who had been on highly active antiretroviral therapy (HAART) for at least one year: (1) insufficient response to (HAART) and presence of AIDS-defining diseases, (2) comorbidity, and (3) drug and alcohol abuse and compared the mortality to that of the general population.
In a Danish nationwide, population-based cohort study, we used population based registries to identify (1) all Danish HIV-infected patients who started HAART in the period 1 January 1998-1 July 2009, and (2) a comparison cohort of individuals matched on date of birth and gender (N = 2,267 and 9,068, respectively). Study inclusion began 1 year after start of HAART. Patients were categorised hierarchically in four groups according to the three risk factors, which were identified before study inclusion. The main outcome measure was probability of survival from age 25 to 65 years. The probability of survival from age 25 to age 65 was substantially lower in HIV patients [0.48 (95% confidence interval (CI) 0.42-0.55)] compared to the comparison cohort [0.88 (0.86 to 0.90)]. However, in HIV patients with no risk factors (N = 871) the probability of survival was equivalent to that of the general population [0.86 (95% CI 0.77-0.92)]. In contrast, the probability of survival was 0.58 in patients with HIV risk factors (N = 704), 0.30 in patients with comorbidities (N = 479), and 0.03 in patients with drug or alcohol abuse (N = 313).
The increased risk of death in HIV-infected individuals is mainly attributable to risk factors that can be identified prior to or in the initial period of antiretroviral treatment. Mortality in patients without risk factors on a successful HAART is almost identical to that of the non-HIV-infected population. |
|---|---|
| AbstractList | We determined the impact of three factors on mortality in HIV-infected patients who had been on highly active antiretroviral therapy (HAART) for at least one year: (1) insufficient response to (HAART) and presence of AIDS-defining diseases, (2) comorbidity, and (3) drug and alcohol abuse and compared the mortality to that of the general population. In a Danish nationwide, population-based cohort study, we used population based registries to identify (1) all Danish HIV-infected patients who started HAART in the period 1 January 1998-1 July 2009, and (2) a comparison cohort of individuals matched on date of birth and gender (N = 2,267 and 9,068, respectively). Study inclusion began 1 year after start of HAART. Patients were categorised hierarchically in four groups according to the three risk factors, which were identified before study inclusion. The main outcome measure was probability of survival from age 25 to 65 years. The probability of survival from age 25 to age 65 was substantially lower in HIV patients [0.48 (95% confidence interval (CI) 0.42-0.55)] compared to the comparison cohort [0.88 (0.86 to 0.90)]. However, in HIV patients with no risk factors (N = 871) the probability of survival was equivalent to that of the general population [0.86 (95% CI 0.77-0.92)]. In contrast, the probability of survival was 0.58 in patients with HIV risk factors (N = 704), 0.30 in patients with comorbidities (N = 479), and 0.03 in patients with drug or alcohol abuse (N = 313). The increased risk of death in HIV-infected individuals is mainly attributable to risk factors that can be identified prior to or in the initial period of antiretroviral treatment. Mortality in patients without risk factors on a successful HAART is almost identical to that of the non-HIV-infected population. Background We determined the impact of three factors on mortality in HIV-infected patients who had been on highly active antiretroviral therapy (HAART) for at least one year: (1) insufficient response to (HAART) and presence of AIDS-defining diseases, (2) comorbidity, and (3) drug and alcohol abuse and compared the mortality to that of the general population. Methodology/Principal Findings In a Danish nationwide, population-based cohort study, we used population based registries to identify (1) all Danish HIV-infected patients who started HAART in the period 1 January 1998–1 July 2009, and (2) a comparison cohort of individuals matched on date of birth and gender (N = 2,267 and 9,068, respectively). Study inclusion began 1 year after start of HAART. Patients were categorised hierarchically in four groups according to the three risk factors, which were identified before study inclusion. The main outcome measure was probability of survival from age 25 to 65 years. The probability of survival from age 25 to age 65 was substantially lower in HIV patients [0.48 (95% confidence interval (CI) 0.42–0.55)] compared to the comparison cohort [0.88 (0.86 to 0.90)]. However, in HIV patients with no risk factors (N = 871) the probability of survival was equivalent to that of the general population [0.86 (95% CI 0.77–0.92)]. In contrast, the probability of survival was 0.58 in patients with HIV risk factors (N = 704), 0.30 in patients with comorbidities (N = 479), and 0.03 in patients with drug or alcohol abuse (N = 313). Conclusions The increased risk of death in HIV-infected individuals is mainly attributable to risk factors that can be identified prior to or in the initial period of antiretroviral treatment. Mortality in patients without risk factors on a successful HAART is almost identical to that of the non–HIV-infected population. Background We determined the impact of three factors on mortality in HIV-infected patients who had been on highly active antiretroviral therapy (HAART) for at least one year: (1) insufficient response to (HAART) and presence of AIDS-defining diseases, (2) comorbidity, and (3) drug and alcohol abuse and compared the mortality to that of the general population. Methodology/Principal Findings In a Danish nationwide, population-based cohort study, we used population based registries to identify (1) all Danish HIV-infected patients who started HAART in the period 1 January 1998-1 July 2009, and (2) a comparison cohort of individuals matched on date of birth and gender (N = 2,267 and 9,068, respectively). Study inclusion began 1 year after start of HAART. Patients were categorised hierarchically in four groups according to the three risk factors, which were identified before study inclusion. The main outcome measure was probability of survival from age 25 to 65 years. The probability of survival from age 25 to age 65 was substantially lower in HIV patients [0.48 (95% confidence interval (CI) 0.42-0.55)] compared to the comparison cohort [0.88 (0.86 to 0.90)]. However, in HIV patients with no risk factors (N = 871) the probability of survival was equivalent to that of the general population [0.86 (95% CI 0.77-0.92)]. In contrast, the probability of survival was 0.58 in patients with HIV risk factors (N = 704), 0.30 in patients with comorbidities (N = 479), and 0.03 in patients with drug or alcohol abuse (N = 313). Conclusions The increased risk of death in HIV-infected individuals is mainly attributable to risk factors that can be identified prior to or in the initial period of antiretroviral treatment. Mortality in patients without risk factors on a successful HAART is almost identical to that of the non-HIV-infected population. We determined the impact of three factors on mortality in HIV-infected patients who had been on highly active antiretroviral therapy (HAART) for at least one year: (1) insufficient response to (HAART) and presence of AIDS-defining diseases, (2) comorbidity, and (3) drug and alcohol abuse and compared the mortality to that of the general population. In a Danish nationwide, population-based cohort study, we used population based registries to identify (1) all Danish HIV-infected patients who started HAART in the period 1 January 1998-1 July 2009, and (2) a comparison cohort of individuals matched on date of birth and gender (N = 2,267 and 9,068, respectively). Study inclusion began 1 year after start of HAART. Patients were categorised hierarchically in four groups according to the three risk factors, which were identified before study inclusion. The main outcome measure was probability of survival from age 25 to 65 years. The probability of survival from age 25 to age 65 was substantially lower in HIV patients [0.48 (95% confidence interval (CI) 0.42-0.55)] compared to the comparison cohort [0.88 (0.86 to 0.90)]. However, in HIV patients with no risk factors (N = 871) the probability of survival was equivalent to that of the general population [0.86 (95% CI 0.77-0.92)]. In contrast, the probability of survival was 0.58 in patients with HIV risk factors (N = 704), 0.30 in patients with comorbidities (N = 479), and 0.03 in patients with drug or alcohol abuse (N = 313). The increased risk of death in HIV-infected individuals is mainly attributable to risk factors that can be identified prior to or in the initial period of antiretroviral treatment. Mortality in patients without risk factors on a successful HAART is almost identical to that of the non-HIV-infected population. We determined the impact of three factors on mortality in HIV-infected patients who had been on highly active antiretroviral therapy (HAART) for at least one year: (1) insufficient response to (HAART) and presence of AIDS-defining diseases, (2) comorbidity, and (3) drug and alcohol abuse and compared the mortality to that of the general population.BACKGROUNDWe determined the impact of three factors on mortality in HIV-infected patients who had been on highly active antiretroviral therapy (HAART) for at least one year: (1) insufficient response to (HAART) and presence of AIDS-defining diseases, (2) comorbidity, and (3) drug and alcohol abuse and compared the mortality to that of the general population.In a Danish nationwide, population-based cohort study, we used population based registries to identify (1) all Danish HIV-infected patients who started HAART in the period 1 January 1998-1 July 2009, and (2) a comparison cohort of individuals matched on date of birth and gender (N = 2,267 and 9,068, respectively). Study inclusion began 1 year after start of HAART. Patients were categorised hierarchically in four groups according to the three risk factors, which were identified before study inclusion. The main outcome measure was probability of survival from age 25 to 65 years. The probability of survival from age 25 to age 65 was substantially lower in HIV patients [0.48 (95% confidence interval (CI) 0.42-0.55)] compared to the comparison cohort [0.88 (0.86 to 0.90)]. However, in HIV patients with no risk factors (N = 871) the probability of survival was equivalent to that of the general population [0.86 (95% CI 0.77-0.92)]. In contrast, the probability of survival was 0.58 in patients with HIV risk factors (N = 704), 0.30 in patients with comorbidities (N = 479), and 0.03 in patients with drug or alcohol abuse (N = 313).METHODOLOGY/PRINCIPAL FINDINGSIn a Danish nationwide, population-based cohort study, we used population based registries to identify (1) all Danish HIV-infected patients who started HAART in the period 1 January 1998-1 July 2009, and (2) a comparison cohort of individuals matched on date of birth and gender (N = 2,267 and 9,068, respectively). Study inclusion began 1 year after start of HAART. Patients were categorised hierarchically in four groups according to the three risk factors, which were identified before study inclusion. The main outcome measure was probability of survival from age 25 to 65 years. The probability of survival from age 25 to age 65 was substantially lower in HIV patients [0.48 (95% confidence interval (CI) 0.42-0.55)] compared to the comparison cohort [0.88 (0.86 to 0.90)]. However, in HIV patients with no risk factors (N = 871) the probability of survival was equivalent to that of the general population [0.86 (95% CI 0.77-0.92)]. In contrast, the probability of survival was 0.58 in patients with HIV risk factors (N = 704), 0.30 in patients with comorbidities (N = 479), and 0.03 in patients with drug or alcohol abuse (N = 313).The increased risk of death in HIV-infected individuals is mainly attributable to risk factors that can be identified prior to or in the initial period of antiretroviral treatment. Mortality in patients without risk factors on a successful HAART is almost identical to that of the non-HIV-infected population.CONCLUSIONSThe increased risk of death in HIV-infected individuals is mainly attributable to risk factors that can be identified prior to or in the initial period of antiretroviral treatment. Mortality in patients without risk factors on a successful HAART is almost identical to that of the non-HIV-infected population. |
| Audience | Academic |
| Author | Kronborg, Gitte Pedersen, Court Obel, Niels Larsen, Carsten S. Pedersen, Gitte Gerstoft, Jan Sørensen, Henrik Toft Omland, Lars Haukali |
| AuthorAffiliation | 5 Department of Infectious Diseases, Aarhus University Hospital, Aalborg Sygehus, Aalborg, Denmark 7 Department of Epidemiology, Boston University School of Public Health, Boston, Massachusetts, United States of America 6 Department of Clinical Epidemiology, Aarhus University Hospital, Aarhus Sygehus, Aarhus N, Denmark 4 Department of Infectious Diseases, Odense University Hospital, Odense C, Denmark 2 Department of Infectious Diseases, Copenhagen University Hospital, Hvidovre Hospital, Hvidovre, Denmark University of Cape Town, South Africa 3 Department of Infectious Diseases, Aarhus University Hospital, Aarhus Sygehus, Aarhus N, Denmark 1 Department of Infectious Diseases, Copenhagen University Hospital, Rigshospitalet, Copenhagen, Denmark |
| AuthorAffiliation_xml | – name: 2 Department of Infectious Diseases, Copenhagen University Hospital, Hvidovre Hospital, Hvidovre, Denmark – name: 6 Department of Clinical Epidemiology, Aarhus University Hospital, Aarhus Sygehus, Aarhus N, Denmark – name: 4 Department of Infectious Diseases, Odense University Hospital, Odense C, Denmark – name: University of Cape Town, South Africa – name: 3 Department of Infectious Diseases, Aarhus University Hospital, Aarhus Sygehus, Aarhus N, Denmark – name: 1 Department of Infectious Diseases, Copenhagen University Hospital, Rigshospitalet, Copenhagen, Denmark – name: 5 Department of Infectious Diseases, Aarhus University Hospital, Aalborg Sygehus, Aalborg, Denmark – name: 7 Department of Epidemiology, Boston University School of Public Health, Boston, Massachusetts, United States of America |
| Author_xml | – sequence: 1 givenname: Niels surname: Obel fullname: Obel, Niels – sequence: 2 givenname: Lars Haukali surname: Omland fullname: Omland, Lars Haukali – sequence: 3 givenname: Gitte surname: Kronborg fullname: Kronborg, Gitte – sequence: 4 givenname: Carsten S. surname: Larsen fullname: Larsen, Carsten S. – sequence: 5 givenname: Court surname: Pedersen fullname: Pedersen, Court – sequence: 6 givenname: Gitte surname: Pedersen fullname: Pedersen, Gitte – sequence: 7 givenname: Henrik Toft surname: Sørensen fullname: Sørensen, Henrik Toft – sequence: 8 givenname: Jan surname: Gerstoft fullname: Gerstoft, Jan |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/21799935$$D View this record in MEDLINE/PubMed |
| BookMark | eNqNk11v0zAUhiM0xD7gHyCwNAnERYpj58u7QCoVo5GmbWrHbi3XdlqX1C6xU9gdPx2nTVEzTQjlwvE5z3lP_Ob4NDjSRssgeB3BQYSz6OPSNLVm1WDtwwMIEUpJ_iw4iQhGYYogPjp4Pw5OrV1CmOA8TV8ExyjKCCE4OQl-F6s14w6YElwbHY6Le8C0AO06UfY7uPRJU1tgNJg29UZtWAWUbvNhoUvJnRTgljkltdtC4-FwcncBhuDWrJvKJ7zoZ2Y9db3d_FRCgpFZmNqBqWvEw8vgeckqK19161nw7fLL3WgcXt18LUbDq5BnSeZClggmIMMJSSDKSkJQKlgsoI_xjGexiAhHghMspShTlKczxjJJOEQ59AZE-Cx4u9NdV8bSzjxLIwyTBGV5mnii2BHCsCVd12rF6gdqmKLbgKnnlNVO8UrSMhWIZRATks9iDBFJiEwlT7ggvMxZ2-1T162ZraTg3p6aVT3RfkarBZ2bDcVRjKMce4H3nUBtfjTSOrpSlsuqYlqaxtI8hxEm_n968vwR-fThOmrO_PcrXRrflreadBhnaZ5jsu06eILyj5Arxf2glcrHewUfegWecfKXm7PGWlpMJ__P3tz32XcH7EKyyi2sqZp2hGwffHNo9F-H9xPugYsdwGtjbS1LypXbjqI_mqpoBGl7nfam0fY60e46-eL4UfFe_59lfwChICJV |
| CitedBy_id | crossref_primary_10_1111_jvh_12290 crossref_primary_10_1136_bmjopen_2022_069637 crossref_primary_10_1080_09540121_2022_2067518 crossref_primary_10_1007_s10461_017_1918_z crossref_primary_10_1097_QAI_0000000000001033 crossref_primary_10_1371_journal_pone_0180761 crossref_primary_10_1177_15347346211009404 crossref_primary_10_1136_jramc_2015_000428 crossref_primary_10_1097_QCO_0b013e32835ba6b1 crossref_primary_10_1093_cid_cis933 crossref_primary_10_1097_MD_0000000000001081 crossref_primary_10_1016_j_ajic_2019_05_028 crossref_primary_10_1007_s10461_013_0575_0 crossref_primary_10_1177_0956462415577496 crossref_primary_10_1017_S0950268816003149 crossref_primary_10_1159_000489172 crossref_primary_10_1186_s12884_021_04357_5 crossref_primary_10_1111_ijd_17529 crossref_primary_10_1016_j_jiac_2024_02_012 crossref_primary_10_1111_j_1468_1293_2012_01055_x crossref_primary_10_1017_S0959259813000208 crossref_primary_10_1111_add_13597 crossref_primary_10_1016_S2352_3018_18_30336_9 crossref_primary_10_1097_QAD_0000000000001830 crossref_primary_10_1371_journal_pone_0256452 crossref_primary_10_1111_hiv_12937 crossref_primary_10_1186_s40168_024_01815_y crossref_primary_10_1097_QAD_0000000000003972 crossref_primary_10_3109_00365548_2012_684220 crossref_primary_10_1097_QAD_0000000000000184 crossref_primary_10_1097_QAI_0000000000003314 crossref_primary_10_1258_ijsa_2012_011412 crossref_primary_10_1186_1471_2334_12_293 crossref_primary_10_1016_j_biopsych_2012_02_018 crossref_primary_10_1097_QAD_0000000000000989 crossref_primary_10_1016_j_tmaid_2013_10_006 crossref_primary_10_1007_s10461_014_0847_3 crossref_primary_10_3390_biomedicines12092060 crossref_primary_10_3109_23744235_2015_1061204 crossref_primary_10_1177_17455065211068688 crossref_primary_10_1371_journal_pone_0072066 crossref_primary_10_1371_journal_pone_0160460 crossref_primary_10_1097_QAI_0000000000001191 crossref_primary_10_3233_HAB_220011 crossref_primary_10_1186_s12877_022_03477_7 crossref_primary_10_1007_s15010_020_01406_7 crossref_primary_10_1080_09540121_2019_1612013 crossref_primary_10_1111_dar_12223 crossref_primary_10_1111_add_12367 crossref_primary_10_1155_2012_670957 crossref_primary_10_1016_j_drugpo_2020_102729 crossref_primary_10_7448_IAS_18_1_19962 crossref_primary_10_1097_QAI_0b013e3182a61ea9 crossref_primary_10_3390_microorganisms13020321 crossref_primary_10_1080_09540121_2021_1916873 crossref_primary_10_1097_QAD_0000000000001335 crossref_primary_10_1007_s11904_012_0137_5 crossref_primary_10_3925_jjtc_71_505 crossref_primary_10_4254_wjh_v8_i31_1295 crossref_primary_10_1371_journal_pone_0072257 crossref_primary_10_1097_QAI_0000000000000825 crossref_primary_10_1371_journal_pone_0057777 crossref_primary_10_1186_s12879_018_3336_x crossref_primary_10_1080_09540121_2020_1772955 crossref_primary_10_1097_JAN_0000000000000220 crossref_primary_10_1097_QAD_0000000000000804 crossref_primary_10_1097_COH_0b013e328354bcc8 crossref_primary_10_1111_acer_12129 crossref_primary_10_1371_journal_pmed_1001718 crossref_primary_10_1007_s15010_012_0293_y crossref_primary_10_1007_s13555_022_00722_0 crossref_primary_10_1097_QAD_0000000000000257 crossref_primary_10_1007_s10461_020_03062_2 crossref_primary_10_1097_QAD_0000000000003402 crossref_primary_10_3390_diagnostics7020031 crossref_primary_10_1016_j_respe_2018_10_006 crossref_primary_10_1089_jwh_2019_8284 crossref_primary_10_2217_fvl_12_25 crossref_primary_10_1186_s12879_018_3518_6 crossref_primary_10_1136_bmjopen_2018_027761 crossref_primary_10_1186_s13104_017_2521_0 crossref_primary_10_1177_0956462415589524 crossref_primary_10_1186_s12885_016_2881_1 crossref_primary_10_1371_journal_pone_0233965 crossref_primary_10_7448_IAS_17_1_19036 crossref_primary_10_12968_hmed_2017_78_9_516 crossref_primary_10_1371_journal_pone_0089089 crossref_primary_10_1371_journal_pone_0188088 crossref_primary_10_1007_s13365_014_0271_5 crossref_primary_10_1111_j_1468_1293_2012_01057_x crossref_primary_10_1016_j_rce_2013_03_012 crossref_primary_10_1136_jramc_2013_000114 crossref_primary_10_1111_hiv_13304 crossref_primary_10_1371_journal_pone_0246999 crossref_primary_10_1177_1545109712444755 crossref_primary_10_3390_nu14030428 crossref_primary_10_1080_23744235_2016_1201722 crossref_primary_10_1097_QAD_0000000000004113 crossref_primary_10_1136_bmjopen_2020_044565 crossref_primary_10_1371_journal_pone_0051698 crossref_primary_10_1002_jmv_23679 crossref_primary_10_1016_j_drugalcdep_2017_07_016 crossref_primary_10_1186_s41100_019_0245_4 crossref_primary_10_1093_ije_dyu153 crossref_primary_10_7448_IAS_19_1_20617 crossref_primary_10_1080_15381501_2013_826611 crossref_primary_10_3390_ijerph19095649 crossref_primary_10_3390_jcm8081125 crossref_primary_10_1097_QAD_0000000000000032 crossref_primary_10_1080_10826084_2017_1334064 crossref_primary_10_1093_ageing_afu016 crossref_primary_10_1371_journal_pone_0176719 crossref_primary_10_1097_QAI_0000000000003107 |
| Cites_doi | 10.1086/498515 10.1136/bmj.a3172 10.1097/01.mlr.0000182534.19832.83 10.1016/S0140-6736(03)14307-3 10.1056/NEJMoa030218 10.1016/S0140-6736(08)60423-7 10.1093/ije/dyn192 10.1001/jama.300.1.51 10.1016/0021-9681(87)90171-8 10.1086/375844 10.1016/j.jclinepi.2006.11.004 10.7326/0003-4819-146-2-200701160-00003 10.3109/00365548.2010.511258 10.1126/science.287.5462.2398 10.1097/QAI.0b013e318134257a 10.1086/503569 10.1016/S0140-6736(10)60932-4 |
| ContentType | Journal Article |
| Copyright | COPYRIGHT 2011 Public Library of Science 2011 Obel et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License: https://creativecommons.org/licenses/by/4.0/ (the “License”), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. Obel et al. 2011 |
| Copyright_xml | – notice: COPYRIGHT 2011 Public Library of Science – notice: 2011 Obel et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License: https://creativecommons.org/licenses/by/4.0/ (the “License”), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. – notice: Obel et al. 2011 |
| DBID | AAYXX CITATION CGR CUY CVF ECM EIF NPM IOV ISR 3V. 7QG 7QL 7QO 7RV 7SN 7SS 7T5 7TG 7TM 7U9 7X2 7X7 7XB 88E 8AO 8C1 8FD 8FE 8FG 8FH 8FI 8FJ 8FK ABJCF ABUWG AEUYN AFKRA ARAPS ATCPS AZQEC BBNVY BENPR BGLVJ BHPHI C1K CCPQU D1I DWQXO FR3 FYUFA GHDGH GNUQQ H94 HCIFZ K9. KB. KB0 KL. L6V LK8 M0K M0S M1P M7N M7P M7S NAPCQ P5Z P62 P64 PATMY PDBOC PHGZM PHGZT PIMPY PJZUB PKEHL PPXIY PQEST PQGLB PQQKQ PQUKI PRINS PTHSS PYCSY RC3 7X8 5PM DOA |
| DOI | 10.1371/journal.pone.0022698 |
| DatabaseName | CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed Gale In Context: Opposing Viewpoints Science in Context ProQuest Central (Corporate) Animal Behavior Abstracts Bacteriology Abstracts (Microbiology B) Biotechnology Research Abstracts Nursing & Allied Health Database Ecology Abstracts Entomology Abstracts (Full archive) Immunology Abstracts Meteorological & Geoastrophysical Abstracts Nucleic Acids Abstracts Virology and AIDS Abstracts Agricultural Science Collection Health & Medical Collection ProQuest Central (purchase pre-March 2016) Medical Database (Alumni Edition) ProQuest Pharma Collection Public Health Database Technology Research Database ProQuest SciTech Collection ProQuest Technology Collection ProQuest Natural Science Collection Hospital Premium Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) ProQuest Materials Science & Engineering ProQuest Central (Alumni) ProQuest One Sustainability ProQuest Central UK/Ireland Advanced Technologies & Computer Science Collection Agricultural & Environmental Science Collection ProQuest Central Essentials Biological Science Collection ProQuest Central Technology collection Natural Science Collection Environmental Sciences and Pollution Management ProQuest One Community College ProQuest Materials Science Collection ProQuest Central Engineering Research Database Health Research Premium Collection Health Research Premium Collection (Alumni) ProQuest Central Student AIDS and Cancer Research Abstracts SciTech Premium Collection ProQuest Health & Medical Complete (Alumni) Materials Science Database Nursing & Allied Health Database (Alumni Edition) Meteorological & Geoastrophysical Abstracts - Academic ProQuest Engineering Collection ProQuest Biological Science Collection Agriculture Science Database Health & Medical Collection (Alumni Edition) PML(ProQuest Medical Library) Algology Mycology and Protozoology Abstracts (Microbiology C) Biological Science Database Engineering Database Nursing & Allied Health Premium ProQuest advanced technologies & aerospace journals ProQuest Advanced Technologies & Aerospace Collection Biotechnology and BioEngineering Abstracts Environmental Science Database Materials Science Collection ProQuest Central Premium ProQuest One Academic Publicly Available Content Database ProQuest Health & Medical Research Collection ProQuest One Academic Middle East (New) ProQuest One Health & Nursing ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Applied & Life Sciences ProQuest One Academic (retired) ProQuest One Academic UKI Edition ProQuest Central China Engineering collection Environmental Science Collection Genetics Abstracts MEDLINE - Academic PubMed Central (Full Participant titles) DOAJ Directory of Open Access Journals |
| DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) Agricultural Science Database Publicly Available Content Database ProQuest Central Student ProQuest Advanced Technologies & Aerospace Collection ProQuest Central Essentials Nucleic Acids Abstracts SciTech Premium Collection ProQuest Central China Environmental Sciences and Pollution Management ProQuest One Applied & Life Sciences ProQuest One Sustainability Health Research Premium Collection Meteorological & Geoastrophysical Abstracts Natural Science Collection Health & Medical Research Collection Biological Science Collection ProQuest Central (New) ProQuest Medical Library (Alumni) Engineering Collection Advanced Technologies & Aerospace Collection Engineering Database Virology and AIDS Abstracts ProQuest Biological Science Collection ProQuest One Academic Eastern Edition Agricultural Science Collection ProQuest Hospital Collection ProQuest Technology Collection Health Research Premium Collection (Alumni) Biological Science Database Ecology Abstracts ProQuest Hospital Collection (Alumni) Biotechnology and BioEngineering Abstracts Environmental Science Collection Entomology Abstracts Nursing & Allied Health Premium ProQuest Health & Medical Complete ProQuest One Academic UKI Edition Environmental Science Database ProQuest Nursing & Allied Health Source (Alumni) Engineering Research Database ProQuest One Academic Meteorological & Geoastrophysical Abstracts - Academic ProQuest One Academic (New) Technology Collection Technology Research Database ProQuest One Academic Middle East (New) Materials Science Collection ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) ProQuest One Community College ProQuest One Health & Nursing ProQuest Natural Science Collection ProQuest Pharma Collection ProQuest Central ProQuest Health & Medical Research Collection Genetics Abstracts ProQuest Engineering Collection Biotechnology Research Abstracts Health and Medicine Complete (Alumni Edition) ProQuest Central Korea Bacteriology Abstracts (Microbiology B) Algology Mycology and Protozoology Abstracts (Microbiology C) Agricultural & Environmental Science Collection AIDS and Cancer Research Abstracts Materials Science Database ProQuest Materials Science Collection ProQuest Public Health ProQuest Nursing & Allied Health Source ProQuest SciTech Collection Advanced Technologies & Aerospace Database ProQuest Medical Library Animal Behavior Abstracts Materials Science & Engineering Collection Immunology Abstracts ProQuest Central (Alumni) MEDLINE - Academic |
| DatabaseTitleList | MEDLINE MEDLINE - Academic Agricultural Science Database |
| Database_xml | – sequence: 1 dbid: DOA name: DOAJ Directory of Open Access Journals url: https://www.doaj.org/ sourceTypes: Open Website – sequence: 2 dbid: NPM name: PubMed url: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 3 dbid: PIMPY name: Publicly Available Content Database url: http://search.proquest.com/publiccontent sourceTypes: Aggregation Database |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Sciences (General) Medicine |
| DocumentTitleAlternate | Survival in HIV-Infected Patients on HAART |
| EISSN | 1932-6203 |
| ExternalDocumentID | 1305527865 oai_doaj_org_article_f6d2a703998b4302959e6ec5cd9cf8a1 PMC3143183 2900071101 A476883983 21799935 10_1371_journal_pone_0022698 |
| Genre | Research Support, Non-U.S. Gov't Journal Article |
| GeographicLocations | Denmark |
| GeographicLocations_xml | – name: Denmark |
| GroupedDBID | --- 123 29O 2WC 53G 5VS 7RV 7X2 7X7 7XC 88E 8AO 8C1 8CJ 8FE 8FG 8FH 8FI 8FJ A8Z AAFWJ AAUCC AAWOE AAYXX ABDBF ABIVO ABJCF ABUWG ACCTH ACGFO ACIHN ACIWK ACPRK ACUHS ADBBV ADRAZ AEAQA AENEX AEUYN AFFHD AFKRA AFPKN AFRAH AHMBA ALMA_UNASSIGNED_HOLDINGS AOIJS APEBS ARAPS ATCPS BAWUL BBNVY BCNDV BENPR BGLVJ BHPHI BKEYQ BPHCQ BVXVI BWKFM CCPQU CITATION CS3 D1I D1J D1K DIK DU5 E3Z EAP EAS EBD EMOBN ESX EX3 F5P FPL FYUFA GROUPED_DOAJ GX1 HCIFZ HH5 HMCUK HYE IAO IEA IGS IHR IHW INH INR IOV IPNFZ IPY ISE ISR ITC K6- KB. KQ8 L6V LK5 LK8 M0K M1P M48 M7P M7R M7S M~E NAPCQ O5R O5S OK1 OVT P2P P62 PATMY PDBOC PHGZM PHGZT PIMPY PJZUB PPXIY PQGLB PQQKQ PROAC PSQYO PTHSS PYCSY RIG RNS RPM SV3 TR2 UKHRP WOQ WOW ~02 ~KM ALIPV CGR CUY CVF ECM EIF NPM PV9 RZL BBORY 3V. 7QG 7QL 7QO 7SN 7SS 7T5 7TG 7TM 7U9 7XB 8FD 8FK AZQEC C1K DWQXO FR3 GNUQQ H94 K9. KL. M7N P64 PKEHL PQEST PQUKI PRINS RC3 7X8 ESTFP PUEGO 5PM - 02 AAPBV ABPTK ADACO BBAFP KM |
| ID | FETCH-LOGICAL-c757t-a5dad0a3595027f9926da4d0d0ac7c74d19c2dc93eedf6286baa7e9c028020313 |
| IEDL.DBID | FPL |
| ISICitedReferencesCount | 121 |
| ISICitedReferencesURI | http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=000293172900068&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| ISSN | 1932-6203 |
| IngestDate | Thu Nov 25 14:37:22 EST 2021 Tue Oct 14 19:06:46 EDT 2025 Tue Nov 04 02:02:45 EST 2025 Wed Oct 01 13:11:37 EDT 2025 Sat Nov 29 14:59:52 EST 2025 Sat Nov 29 13:15:06 EST 2025 Sat Nov 29 10:02:29 EST 2025 Wed Nov 26 09:23:41 EST 2025 Wed Nov 26 09:26:30 EST 2025 Thu May 22 21:19:57 EDT 2025 Mon Jul 21 05:50:02 EDT 2025 Sat Nov 29 04:26:54 EST 2025 Tue Nov 18 22:32:12 EST 2025 |
| IsDoiOpenAccess | true |
| IsOpenAccess | true |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 7 |
| Language | English |
| License | This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are properly credited. Creative Commons Attribution License |
| LinkModel | DirectLink |
| MergedId | FETCHMERGED-LOGICAL-c757t-a5dad0a3595027f9926da4d0d0ac7c74d19c2dc93eedf6286baa7e9c028020313 |
| Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 Conceived and designed the experiments: NO. Performed the experiments: NO. Analyzed the data: NO LHO GK CSL CP GP HTS JG. Contributed reagents/materials/analysis tools: NO LHO GK CSL CP GP HTS JG. Wrote the paper: NO. Reviewed the first draft of the paper and approved the manuscript: NO LHO GK CSL CP GP HTS JG. |
| OpenAccessLink | http://dx.doi.org/10.1371/journal.pone.0022698 |
| PMID | 21799935 |
| PQID | 1305527865 |
| PQPubID | 1436336 |
| PageCount | e22698 |
| ParticipantIDs | plos_journals_1305527865 doaj_primary_oai_doaj_org_article_f6d2a703998b4302959e6ec5cd9cf8a1 pubmedcentral_primary_oai_pubmedcentral_nih_gov_3143183 proquest_miscellaneous_880139538 proquest_journals_1305527865 gale_infotracmisc_A476883983 gale_infotracacademiconefile_A476883983 gale_incontextgauss_ISR_A476883983 gale_incontextgauss_IOV_A476883983 gale_healthsolutions_A476883983 pubmed_primary_21799935 crossref_citationtrail_10_1371_journal_pone_0022698 crossref_primary_10_1371_journal_pone_0022698 |
| PublicationCentury | 2000 |
| PublicationDate | 2011-07-25 |
| PublicationDateYYYYMMDD | 2011-07-25 |
| PublicationDate_xml | – month: 07 year: 2011 text: 2011-07-25 day: 25 |
| PublicationDecade | 2010 |
| PublicationPlace | United States |
| PublicationPlace_xml | – name: United States – name: San Francisco – name: San Francisco, USA |
| PublicationTitle | PloS one |
| PublicationTitleAlternate | PLoS One |
| PublicationYear | 2011 |
| Publisher | Public Library of Science Public Library of Science (PLoS) |
| Publisher_xml | – name: Public Library of Science – name: Public Library of Science (PLoS) |
| References | ME Charlson (ref12) 1987; 40 M Saves (ref16) 2003; 37 C Lewden (ref19) 2007; 46 MV Larsen (ref3) 2010; 42 K Bhaskaran (ref17) 2008; 300 KJ Rothman (ref15) 2002 KJ Rothman (ref20) 2002 SG Deeks (ref7) 2009; 338 N Obel (ref9) 2009; 38 RK Lodwick (ref8) 2010; 376 C Jaggy (ref18) 2003; 362 H Quan (ref13) 2005; 43 CA Sabin (ref5) 2008; 371 N Lohse (ref1) 2007; 146 N Friis-Moller (ref2) 2003; 349 AP Zavascki (ref14) 2007; 60 TF Andersen (ref11) 1999; 46 L Frank (ref10) 2000; 287 N Lohse (ref4) 2006; 42 N Weis (ref6) 2006; 42 18594040 - JAMA. 2008 Jul 2;300(1):51-9 16619163 - Clin Infect Dis. 2006 May 15;42(10):1481-7 20638118 - Lancet. 2010 Jul 31;376(9738):340-5 19171560 - BMJ. 2009;338:a3172 12856222 - Clin Infect Dis. 2003 Jul 15;37(2):292-8 13678976 - Lancet. 2003 Sep 13;362(9387):877-8 20840000 - Scand J Infect Dis. 2010 Dec;42(11-12):917-23 17689801 - J Clin Epidemiol. 2007 Sep;60(9):867-8 18799495 - Int J Epidemiol. 2009 Oct;38(5):1202-6 18387667 - Lancet. 2008 Apr 26;371(9622):1417-26 16224307 - Med Care. 2005 Nov;43(11):1130-9 3558716 - J Chronic Dis. 1987;40(5):373-83 17227932 - Ann Intern Med. 2007 Jan 16;146(2):87-95 10766613 - Science. 2000 Mar 31;287(5462):2398-9 10421985 - Dan Med Bull. 1999 Jun;46(3):263-8 17621240 - J Acquir Immune Defic Syndr. 2007 Sep 1;46(1):72-7 16323104 - Clin Infect Dis. 2006 Jan 1;42(1):136-44 14627784 - N Engl J Med. 2003 Nov 20;349(21):1993-2003 |
| References_xml | – volume: 42 start-page: 136 year: 2006 ident: ref4 article-title: Virological control during the first 6–18 months after initiating highly active antiretroviral therapy as a predictor for outcome in HIV-infected patients: A Danish, population-based, 6-year follow-up study. publication-title: Clin Infect Dis doi: 10.1086/498515 – volume: 338 start-page: a3172 year: 2009 ident: ref7 article-title: HIV infection, antiretroviral treatment, ageing, and non-AIDS related morbidity. publication-title: BMJ doi: 10.1136/bmj.a3172 – volume: 43 start-page: 1130 year: 2005 ident: ref13 article-title: Coding algorithms for defining comorbidities in ICD-9-CM and ICD-10 administrative data. publication-title: Med Care doi: 10.1097/01.mlr.0000182534.19832.83 – volume: 362 start-page: 877 year: 2003 ident: ref18 article-title: Mortality in the Swiss HIV Cohort Study (SHCS) and the Swiss general population. publication-title: Lancet doi: 10.1016/S0140-6736(03)14307-3 – volume: 349 start-page: 1993 year: 2003 ident: ref2 article-title: Combination antiretroviral therapy and the risk of myocardial infarction. publication-title: N Engl J Med doi: 10.1056/NEJMoa030218 – volume: 371 start-page: 1417 year: 2008 ident: ref5 article-title: Use of nucleoside reverse transcriptase inhibitors and risk of myocardial infarction in HIV-infected patients enrolled in the D:A:D study: a multi-cohort collaboration. publication-title: Lancet doi: 10.1016/S0140-6736(08)60423-7 – volume: 38 start-page: 1202 year: 2009 ident: ref9 article-title: Cohort profile: the Danish HIV cohort study. publication-title: Int J Epidemiol doi: 10.1093/ije/dyn192 – volume: 300 start-page: 51 year: 2008 ident: ref17 article-title: Changes in the risk of death after HIV seroconversion compared with mortality in the general population. publication-title: JAMA doi: 10.1001/jama.300.1.51 – volume: 40 start-page: 373 year: 1987 ident: ref12 article-title: A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. publication-title: J Chronic Dis doi: 10.1016/0021-9681(87)90171-8 – volume: 46 start-page: 263 year: 1999 ident: ref11 article-title: The Danish National Hospital Register. A valuable source of data for modern health sciences. publication-title: Dan Med Bull – volume: 37 start-page: 292 year: 2003 ident: ref16 article-title: Risk factors for coronary heart disease in patients treated for human immunodeficiency virus infection compared with the general population. publication-title: Clin Infect Dis doi: 10.1086/375844 – volume: 60 start-page: 867 year: 2007 ident: ref14 article-title: The need for reappraisal of AIDS score weight of Charlson comorbidity index. publication-title: J Clin Epidemiol doi: 10.1016/j.jclinepi.2006.11.004 – volume: 146 start-page: 87 year: 2007 ident: ref1 article-title: Survival of persons with and without HIV infection in Denmark, 1995–2005. publication-title: Ann Intern Med doi: 10.7326/0003-4819-146-2-200701160-00003 – volume: 42 start-page: 917 year: 2010 ident: ref3 article-title: Impact of injecting drug use on response to highly active antiretroviral treatment in HIV-1-infected patients: A nationwide population-based cohort study. publication-title: Scand J Infect Dis doi: 10.3109/00365548.2010.511258 – volume: 287 start-page: 2398 year: 2000 ident: ref10 article-title: Epidemiology. When an entire country is a cohort. publication-title: Science doi: 10.1126/science.287.5462.2398 – volume: 46 start-page: 72 year: 2007 ident: ref19 article-title: HIV-infected adults with a CD4 cell count greater than 500 cells/mm3 on long-term combination antiretroviral therapy reach same mortality rates as the general population. publication-title: J Acquir Immune Defic Syndr doi: 10.1097/QAI.0b013e318134257a – volume: 42 start-page: 1481 year: 2006 ident: ref6 article-title: Impact of hepatitis C virus coinfection on response to highly active antiretroviral therapy and outcome in HIV-infected individuals: a nationwide cohort study. publication-title: Clin Infect Dis doi: 10.1086/503569 – volume: 376 start-page: 340 year: 2010 ident: ref8 article-title: Death rates in HIV-positive antiretroviral-naive patients with CD4 count greater than 350 cells per microL in Europe and North America: a pooled cohort observational study. publication-title: Lancet doi: 10.1016/S0140-6736(10)60932-4 – start-page: 130 year: 2002 ident: ref15 article-title: Analyzing Simple Epidemiologic Data. Epidemiology - An Introduction. 1st ed – start-page: 94 year: 2002 ident: ref20 article-title: Biases in Study Design. Epidemiology - An Introduction. 1st ed – reference: 17621240 - J Acquir Immune Defic Syndr. 2007 Sep 1;46(1):72-7 – reference: 16224307 - Med Care. 2005 Nov;43(11):1130-9 – reference: 18799495 - Int J Epidemiol. 2009 Oct;38(5):1202-6 – reference: 17689801 - J Clin Epidemiol. 2007 Sep;60(9):867-8 – reference: 18594040 - JAMA. 2008 Jul 2;300(1):51-9 – reference: 17227932 - Ann Intern Med. 2007 Jan 16;146(2):87-95 – reference: 19171560 - BMJ. 2009;338:a3172 – reference: 12856222 - Clin Infect Dis. 2003 Jul 15;37(2):292-8 – reference: 14627784 - N Engl J Med. 2003 Nov 20;349(21):1993-2003 – reference: 16323104 - Clin Infect Dis. 2006 Jan 1;42(1):136-44 – reference: 20638118 - Lancet. 2010 Jul 31;376(9738):340-5 – reference: 18387667 - Lancet. 2008 Apr 26;371(9622):1417-26 – reference: 13678976 - Lancet. 2003 Sep 13;362(9387):877-8 – reference: 10421985 - Dan Med Bull. 1999 Jun;46(3):263-8 – reference: 16619163 - Clin Infect Dis. 2006 May 15;42(10):1481-7 – reference: 20840000 - Scand J Infect Dis. 2010 Dec;42(11-12):917-23 – reference: 10766613 - Science. 2000 Mar 31;287(5462):2398-9 – reference: 3558716 - J Chronic Dis. 1987;40(5):373-83 |
| SSID | ssj0053866 |
| Score | 2.4094267 |
| Snippet | We determined the impact of three factors on mortality in HIV-infected patients who had been on highly active antiretroviral therapy (HAART) for at least one... Background We determined the impact of three factors on mortality in HIV-infected patients who had been on highly active antiretroviral therapy (HAART) for at... BACKGROUND: We determined the impact of three factors on mortality in HIV-infected patients who had been on highly active antiretroviral therapy (HAART) for at... Background We determined the impact of three factors on mortality in HIV-infected patients who had been on highly active antiretroviral therapy (HAART) for at... |
| SourceID | plos doaj pubmedcentral proquest gale pubmed crossref |
| SourceType | Open Website Open Access Repository Aggregation Database Index Database Enrichment Source |
| StartPage | e22698 |
| SubjectTerms | Acquired immune deficiency syndrome Adult Age AIDS Alcohol abuse Alcoholic beverages Alcoholism Alcoholism - complications Antiretroviral agents Antiretroviral drugs Antiretroviral Therapy, Highly Active Cardiovascular disease Cohort analysis Cohort Studies Comorbidity Confidence intervals Denmark - epidemiology Drug abuse Female Health risk assessment Health risks Highly active antiretroviral therapy HIV HIV infections HIV Infections - complications HIV Infections - drug therapy HIV Infections - epidemiology HIV Infections - mortality HIV patients Human immunodeficiency virus Humans Male Medical diagnosis Medical research Medicine Middle Aged Mortality Patient outcomes Patients Population studies Population-based studies Risk analysis Risk Factors Statistical analysis Survival Survival Analysis Treatment Outcome |
| SummonAdditionalLinks | – databaseName: DOAJ Directory of Open Access Journals dbid: DOA link: http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1Lb9QwELbQigMXRHk1UMBCSMDBNOs8HHNbENWuhAriUfVmObZTVqqS1WaXXvvTmbG9UYMqlQOnleJxtJkZj2fsmW8IeWWmTqelbpjgtWC5qwuma8OZTJu65oJnLoAkfRbHx9Xpqfx6pdUX5oQFeODAuMOmtFyDWkJYUOdZymUhXelMYaw0TaV94JMKuQumgg2GVVyWsVAuE9PDKJd3q651eITCS1mNNiKP1z9Y5cnqvOuvczn_zpy8shUd3SN3ow9JZ-G_75Fbrr1P9uIq7embCCX99gG5XPgiSNo1FMJ8Nl-cUN1air-YU05jtx3atbTfgtEAtaPLFsdZyNJylkbkVU80n4H_-55quhr6fjHcBy0Nh4oXS-so9txdb6gHrn1Ifh59-vFxzmLPBWZEITZMF1bbVGO5LgSsjZS8tDq3KTwzwojcTqXh1sgM9tYGy1prrYWTBm9oOeJAPiIT-CC3Tyh4b05YXUmhszytwbfjRW2nBehCWvCGJyTbCUCZCEiOfTHOlb9lExCYBH4qFJuKYksIG2atAiDHDfQfULYDLcJp-wegZCoqmbpJyRLyAjVDhdrUwSioWQ7RGriYVZaQl54CITVazNk509u-V4svJ_9A9P3biOh1JGo6YIfRsU4CvgmhukaUByNKMAxmNLyPerzjSo83l4i3V5UFzNzp9vXDdBjGl2IeXuu6ba_A2kPIAMsrIY_DShgYyxFbUGYwWYzWyIjz45F2-csDmmfgtMPW8uR_iOopuROO_RGA5IBMNuute0Zum9-bZb9-7q3EH-VSbi8 priority: 102 providerName: Directory of Open Access Journals – databaseName: Nursing & Allied Health Database dbid: 7RV link: http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwpV3Nb9MwFLegcODCGF_rGGAhJODgLXE-HHNB3UTVSqhUHVS7RY7tbBVTUpoWxI0_nfcSNxA0ARKnSvFz1Njv037v9wh5rn2rvFjlTPBMsNBmEVOZ5kx6eZZxwQPbgCS9E5NJcnYmp-7ArXJplVudWCtqU2o8Iz_yEZqKiySO3iw_M-wahberroXGdXLDR98Y-FnM5ltNDLIcx65cLhD-kdudw2VZWDxI4bFMOuaoRu1vdXNveVlWVzmev-dP_mKQhjv_-yl3yG3nitJBwzu75Jot7pJdJ-wVfekQqV_dI9_HdS0lLXM6KQs2Gs-pKgzF39mi-kSHTdMeWhb0dAO6B7iXLgocZ-M62csaOm0AXGui0QDc6Nd0QKdt-zB2DObU0Aam--vCWHpSXkBoQDHR8dt98nH49sPJiLnWDUyLSKyZiowynsKqX4h7cyl5bFRoPHimhRah8aXmRssATHSO1bGZUsJKjRe9HOEkH5BeAdu0Ryg4gVYYlUihgtDLwEXkUWb8CFjKi3jO-yTY7mCqHa45tte4TOvLOgHxTbOeKe576va9T1g7a9ngevyF_hiZo6VFVO76Qbk6T52Qp3lsuAIVCiFsFgYel5G0sdWRNlLnifL75CmyVtqUuLa6JR2EEPSBp5oEffKspkBkjgJTf87VpqrS8fv5PxCdzjpELxxRXsJyaOXKLeCbEPGrQ3nQoQT9ojvDeygI21Wp0p_sCzO3DH71MG2H8aWYzlfYclOlYDQg8gD57JOHjSi1C8sRolAGMFl0hKyz8t2RYnFR46IH4PuDhdr_8796RG419wKIUHJAeuvVxj4mN_WX9aJaPakVyA8A6Xqk priority: 102 providerName: ProQuest |
| Title | Impact of Non-HIV and HIV Risk Factors on Survival in HIV-Infected Patients on HAART: A Population-Based Nationwide Cohort Study |
| URI | https://www.ncbi.nlm.nih.gov/pubmed/21799935 https://www.proquest.com/docview/1305527865 https://www.proquest.com/docview/880139538 https://pubmed.ncbi.nlm.nih.gov/PMC3143183 https://doaj.org/article/f6d2a703998b4302959e6ec5cd9cf8a1 http://dx.doi.org/10.1371/journal.pone.0022698 |
| Volume | 6 |
| WOSCitedRecordID | wos000293172900068&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| journalDatabaseRights | – providerCode: PRVAON databaseName: DOAJ Directory of Open Access Journals customDbUrl: eissn: 1932-6203 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0053866 issn: 1932-6203 databaseCode: DOA dateStart: 20060101 isFulltext: true titleUrlDefault: https://www.doaj.org/ providerName: Directory of Open Access Journals – providerCode: PRVHPJ databaseName: ROAD: Directory of Open Access Scholarly Resources customDbUrl: eissn: 1932-6203 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0053866 issn: 1932-6203 databaseCode: M~E dateStart: 20060101 isFulltext: true titleUrlDefault: https://road.issn.org providerName: ISSN International Centre – providerCode: PRVPQU databaseName: Advanced Technologies & Aerospace Database customDbUrl: eissn: 1932-6203 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0053866 issn: 1932-6203 databaseCode: P5Z dateStart: 20061201 isFulltext: true titleUrlDefault: https://search.proquest.com/hightechjournals providerName: ProQuest – providerCode: PRVPQU databaseName: Agricultural Science Database customDbUrl: eissn: 1932-6203 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0053866 issn: 1932-6203 databaseCode: M0K dateStart: 20061201 isFulltext: true titleUrlDefault: https://search.proquest.com/agriculturejournals providerName: ProQuest – providerCode: PRVPQU databaseName: Biological Science Database customDbUrl: eissn: 1932-6203 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0053866 issn: 1932-6203 databaseCode: M7P dateStart: 20061201 isFulltext: true titleUrlDefault: http://search.proquest.com/biologicalscijournals providerName: ProQuest – providerCode: PRVPQU databaseName: Engineering Database customDbUrl: eissn: 1932-6203 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0053866 issn: 1932-6203 databaseCode: M7S dateStart: 20061201 isFulltext: true titleUrlDefault: http://search.proquest.com providerName: ProQuest – providerCode: PRVPQU databaseName: Environmental Science Database (subscripiton) customDbUrl: eissn: 1932-6203 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0053866 issn: 1932-6203 databaseCode: PATMY dateStart: 20061201 isFulltext: true titleUrlDefault: http://search.proquest.com/environmentalscience providerName: ProQuest – providerCode: PRVPQU databaseName: Materials Science Database customDbUrl: eissn: 1932-6203 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0053866 issn: 1932-6203 databaseCode: KB. dateStart: 20061201 isFulltext: true titleUrlDefault: http://search.proquest.com/materialsscijournals providerName: ProQuest – providerCode: PRVPQU databaseName: Nursing & Allied Health Database customDbUrl: eissn: 1932-6203 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0053866 issn: 1932-6203 databaseCode: 7RV dateStart: 20061201 isFulltext: true titleUrlDefault: https://search.proquest.com/nahs providerName: ProQuest – providerCode: PRVPQU databaseName: ProQuest Central customDbUrl: eissn: 1932-6203 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0053866 issn: 1932-6203 databaseCode: BENPR dateStart: 20061201 isFulltext: true titleUrlDefault: https://www.proquest.com/central providerName: ProQuest – providerCode: PRVPQU databaseName: ProQuest_Health & Medical Collection customDbUrl: eissn: 1932-6203 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0053866 issn: 1932-6203 databaseCode: 7X7 dateStart: 20061201 isFulltext: true titleUrlDefault: https://search.proquest.com/healthcomplete providerName: ProQuest – providerCode: PRVPQU databaseName: Public Health Database customDbUrl: eissn: 1932-6203 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0053866 issn: 1932-6203 databaseCode: 8C1 dateStart: 20061201 isFulltext: true titleUrlDefault: https://search.proquest.com/publichealth providerName: ProQuest – providerCode: PRVPQU databaseName: Publicly Available Content Database customDbUrl: eissn: 1932-6203 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0053866 issn: 1932-6203 databaseCode: PIMPY dateStart: 20061201 isFulltext: true titleUrlDefault: http://search.proquest.com/publiccontent providerName: ProQuest – providerCode: PRVATS databaseName: Public Library of Science (PLoS) Journals Open Access customDbUrl: eissn: 1932-6203 dateEnd: 99991231 omitProxy: false ssIdentifier: ssj0053866 issn: 1932-6203 databaseCode: FPL dateStart: 20060101 isFulltext: true titleUrlDefault: http://www.plos.org/publications/ providerName: Public Library of Science |
| link | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV3Nb9MwFLdYx4ELML5WGMVCSMAhI3GaOObWVqtabStRC1XHJXJsh1VMSbW0IG786byXpIFMm4DLqxQ_V8nL-4z9fibklXKMtH2ZWJzF3Oqa2LNkrJgl7CSOGWeuKUGSTvhkEiwWIvxdKF5ZwXe5866S6eEqSw1-_mC-CHbILnN9H4utYXiy9bxgu75ftcfdNLMRfgqU_toXt1YXWX5donl1v-QfAWh4739v_T65W6WatFfqxh65ZdIHZK8y5py-qRCn3z4kP8dFryTNEjrJUms0nlOZaoq_02X-lQ7LQ3loltLZBnwLaCddpjhujYvNXEbTsARoLZhGPUiT39MeDevjwaw-hEtNSxju70tt6CA7h9Sf4kbGH4_Ip-HRx8HIqo5msBT3-NqSnpbaltjVC3VtIgTztexqG64prnhXO0IxrYQLITjB7tdYSm6EwoVchnCRj0krBansEwpJnuFaBoJLt2vHkAIyL9aOBypjeyxhbeJu31ikKtxyPD7jIioW4zjUL6U8IxRzVIm5Tax61qrE7fgLfx-VoeZF1O3iArzPqDLiKPE1k-AioUSNu67NhCeMb5SntFBJIJ02eYGqFJUtrLXviHpdKOogEw3cNnlZcCDyRopbe77ITZ5H4w_zf2CaTRtMryumJANxKFm1U8AzIaJXg_OgwQn-QzWG91Hxt1LJcYETYfkC34OZW2O4fpjWw_inuF0vNdkmjyAoQGUB9tgmT0rTqQXLEIJQuDCZN4yqIfnmSLo8L3DPXcjtIQI9vfmGn5E75Td_RB85IK315cY8J7fVt_Uyv-yQHT6dI13wggZAg4HTIbv9o0k47RTfYzqFSwF63D8EemofI-VhQWdAQ-8zzAjHp-HZL_DLdWg |
| linkProvider | Public Library of Science |
| linkToHtml | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMw1V1Lb9NAEF6VgAQXoLwaKHSFQNCDqb1-rBcJobQQJWoJUVuqiotZ767biMoOcULVG7-I38iMX2BUAZceOFnyzlrOZJ7emW8IeaIcI-1AJhZnMbc8E_uWjBWzhJ3EMePMNSVI0g4fjcLDQzFeIt_rXhgsq6xtYmGodabwG_mGg9BUjIeB_3r6xcKpUXi6Wo_QKMVi25ydQsqWvxq-gf_3KWP9t_tbA6uaKmAp7vO5JX0ttS2xIRVSskQIFmjpaRvuKa64px2hmFbCBe-RYONmLCU3QuEZJEOkQ3juJXLZ85iNWjT2P9aWH2xHEFTteS53NippeDHNUoMfblggwpb7K6YENL6gMz3J8vMC3d_rNX9xgP0b_xvrbpLrVahNe6VuLJMlk94iy5Uxy-nzCnF7_Tb5Nix6RWmW0FGWWoPhAZWppnjdneSfab8cSkSzlO4twLaCdtJJiuvWsChmM5qOS4DagmjQgzThJe3RcTMezdqEcEHTEob8dKIN3cqOIfWhWMh5dod8uBBO3CWdFMRihVAIcg3XMhRcup4dQwjM_Fg7PqiM7bOEdYlbS0ykKtx2HB9yEhWHkRzyt5KfEcpZVMlZl1jNrmmJW_IX-k0UxoYWUceLG9nsKKqMWJQEmklwEZCix55rM-ELExjlKy1UEkqnS9ZQlKOyhbexnVHPg6QWIvHQ7ZLHBQUij6RY2nQkF3keDd8f_APR3m6L6FlFlGTADiWrdhL4TYho1qJcbVGC_VSt5RVUvJorefRTXWBnrVDnL9NmGR-K5YqpyRZ5BE4RMiuwB11yr1TdhrEMIRiFC5t5S6lbnG-vpJPjAvfdhdwGPPD9P7_VGrk62H-3E-0MR9sPyLXyDATRWFZJZz5bmIfkivo6n-SzR4XxouTTRav8D0mG2D8 |
| linkToPdf | http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMw1V1Lb9NAEF6VgBAXoLwaKHSFQMDBxF4_NouEUNoSxWoVohaqiotZ767biMoOcULVG7-LX8eMX2BUAZceOFnyzlrOZJ7emW8IeaIcI-1AJhZnMbc8E_uWjBWzhJ3EMePMNSVI0i4fj_uHh2KyQr7XvTBYVlnbxMJQ60zhN_Keg9BUjPcDv5dUZRGT7eGb2RcLJ0jhSWs9TqMUkR1zdgrpW_463Ib_-iljw7fvt0ZWNWHAUtznC0v6WmpbYnMqpGeJECzQ0tM23FNccU87QjGthAueJMEmzlhKboTC80iGqIfw3EvkMoccE8sJJ_7H2guAHQmCqlXP5U6vkoyXsyw1-BGHBaLfcoXFxIDGL3RmJ1l-XtD7e-3mL85weON_ZuNNcr0Kwemg1JlVsmLSW2S1MnI5fV4hcb-4Tb6FRQ8pzRI6zlJrFB5QmWqK171p_pkOy2FFNEvp_hJsLmgtnaa4boVFkZvRdFIC1xZEowGkD6_ogE6asWnWJoQRmpbw5KdTbehWdgwpEcUCz7M75MOFcOIu6aQgImuEQvBruJZ9waXr2TGExsyPteODKtk-S1iXuLX0RKrCc8exIidRcUjJIa8r-RmhzEWVzHWJ1eyalXgmf6HfRMFsaBGNvLiRzY-iyrhFSaCZBNcBqXvsuTYTvjCBUb7SQiV96XTJBop1VLb2NjY1GniQ7EKE3ne75HFBgYgkKQrlkVzmeRS-O_gHov29FtGziijJgB1KVm0m8JsQ6axFud6iBLuqWstrqIQ1V_Lop-rAzlq5zl-mzTI-FMsYU5Mt8wicJWRcYBu65F6pxg1jGUIzChc285aCtzjfXkmnxwUevAs5D3jm-39-qw1yFTQ92g3HOw_ItfJoBEFa1klnMV-ah-SK-rqY5vNHhR2j5NNFa_wPGD_hCQ |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Impact+of+Non-HIV+and+HIV+Risk+Factors+on+Survival+in+HIV-Infected+Patients+on+HAART%3A+A+Population-Based+Nationwide+Cohort+Study&rft.jtitle=PloS+one&rft.au=Obel%2C+Niels&rft.au=Omland%2C+Lars+Haukali&rft.au=Kronborg%2C+Gitte&rft.au=Larsen%2C+Carsten+S&rft.date=2011-07-25&rft.pub=Public+Library+of+Science&rft.issn=1932-6203&rft.eissn=1932-6203&rft.volume=6&rft.issue=7&rft.spage=e22698&rft_id=info:doi/10.1371%2Fjournal.pone.0022698&rft.externalDocID=A476883983 |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1932-6203&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1932-6203&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1932-6203&client=summon |